8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001415889-16-006116
Executive or director change · Regulation FD disclosure · Other events
- Item 5.02 Departure or appointment of directors or officers
- Item 7.01 Regulation FD disclosure
- Item 8.01 Other events
From the SEC's structured data for this filing
Loading cdxc8k_jun62016.htm…